The
overall
mutational
burden
HPV-negative
HPV-positive
HNSCC
similar
average
15.2
versus
14.4
somatic
exonic
mutations
targeted
cancer-associated
genes
.

HPV-negative
tumors
showed
mutational
spectrum
concordant
published
lung
squamous
cell
carcinoma
analyses
enrichment
mutations
TP53
,
CDKN2A
,
MLL2
,
CUL3
,
NSD1
,
PIK3CA
,
NOTCH
genes
.

HPV-positive
tumors
showed
unique
mutations
DDX3X
,
FGFR2/3
aberrations
PIK3CA
,
KRAS
,
MLL2/3
,
NOTCH1
enriched
HPV-positive
tumors
.

Currently
targetable
genomic
alterations
identified
FGFR1
,
DDR2
,
EGFR
,
FGFR2/3
,
EPHA2
,
PIK3CA
.

EGFR
,
CCND1
,
FGFR1
amplifications
occurred
HPV-negative
tumors
,
whereas
17.6
%
HPV-positive
tumors
harbored
mutations
fibroblast
growth
factor
receptor
genes
(
FGFR2/3
)
,
including
six
recurrent
FGFR3
S249C
mutations
.

HPV-positive
tumors
showed
5.8
%
incidence
KRAS
mutations
,
DNA-repair
gene
aberrations
,
including
7.8
%
BRCA1/2
mutations
,
identified
.

